Feasibility and efficacy of downstaging treatment for hepatocellula carcinoma over the Milan Criteria.

Feasibility and efficacy of downstaging treatment for hepatocellula carcinoma over the Milan Criteria. - Downstaging treatment for Over Milan HCC.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029281

Enrollment

Registered

2017-09-27

Start date

2016-05-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC

Interventions

Treatment for HCC, TACE, RFA, sorafenib, surgery, PEIT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1,Not greater than 65, not less than Child B 2, HCC of over Milan criteria 3, No distant metastasis, no vascular invasion, tumor size not greater than 8cm. 4, Child wihin 11 5, Patient agreement

Exclusion criteria

Exclusion criteria: 1, Allergy to contrast agent 2, No agreement 3, Active infetion 4, Active double cancer. 5, Active gastrointestinal ulcer 6, Severe comorbidity 7, Severe mental disorder 8, Severe drug allergy

Design outcomes

Primary

Measure	Time frame
Adverse event	—

Secondary

Measure	Time frame
effectiveness achievement rate of transplantation	—

Countries

Japan

Contacts

Public ContactShinoda Masahiro

Keio university school of medicine Surgery

masa02114@z6.keio.jp0333531211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026